Investors may turn to recent quarterly earnings reports to build a list of stock picks.
In the technology software sector, Wix (WIX), a dotcom and a supplier of website building, plunged to a 52-week low. Short sellers hold a 15% short float against the firm, betting that AI will replace its procedural web-building tool. Base44’s AI-powered vibe coding solution might help attract investors.
To win its investors, Wix needs to report better revenue growth from Base44 first.
Monday (MNDY), another dotcom, hovered near a 52-week low. In its Q1/2026 report, the firm posted $49 million in operating profit. For Q2, the CFO is guiding revenue of up to $356 million. Free cash flow for the year is in the range of $280 million to $290 million. Gross margin and product pricing are healthy. The firm is the former to be in the mid-80s.
In the pet drug segment, Zoetis (ZTS) closed last week at a 52-week low of $74.22. The firm posted international organic operational revenue growth of 10%. But this declined by 8% in the all-important U.S. market. The firm will not cut product pricing, even though macro competition is persisting throughout this year.
Investors should exercise caution with drug stocks. Consumers will pull back on pet care as inflation, driven by the oil crisis, persists throughout this month and into the summer.
